134 related articles for article (PubMed ID: 9723646)
1. Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty.
Abbate R; Marcucci R; Camacho-Vanegas O; Pepe G; Gori AM; Capanni M; Simonetti I; Prisco D; Gensini GF
Am J Cardiol; 1998 Aug; 82(4):524-5. PubMed ID: 9723646
[TBL] [Abstract][Full Text] [Related]
2. The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis.
Pamukcu B; Oflaz H; Nisanci Y
Am Heart J; 2005 Apr; 149(4):675-80. PubMed ID: 15990752
[TBL] [Abstract][Full Text] [Related]
3. Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) Study.
Aleksic N; Juneja H; Folsom AR; Ahn C; Boerwinkle E; Chambless LE; Wu KK
Circulation; 2000 Oct; 102(16):1901-5. PubMed ID: 11034936
[TBL] [Abstract][Full Text] [Related]
4. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty.
Samani NJ; Martin DS; Brack M; Cullen J; Chauhan A; Lodwick D; Harley A; Swales JD; de Bono DP; Gershlick AH
Lancet; 1995 Apr; 345(8956):1013-6. PubMed ID: 7723497
[TBL] [Abstract][Full Text] [Related]
5. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
[TBL] [Abstract][Full Text] [Related]
6. Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets.
Bennett JS; Catella-Lawson F; Rut AR; Vilaire G; Qi W; Kapoor SC; Murphy S; FitzGerald GA
Blood; 2001 May; 97(10):3093-9. PubMed ID: 11342435
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein epsilon 4 is not a genetic risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty.
Damaraju S; Yu QT; Safavi F; Marian AJ
Am J Cardiol; 1995 Jun; 75(16):1181-3. PubMed ID: 7762511
[No Abstract] [Full Text] [Related]
8. Apolipoprotein E polymorphism does not predict risk of restenosis after coronary angioplasty.
Samani NJ; Martin DS; Brack M; Cullen J; Wallis R; Lodwick D; Chauhan A; Harley A; Thompson JR; Gershlick AH; de Bono DP
Atherosclerosis; 1996 Sep; 125(2):209-16. PubMed ID: 8842352
[TBL] [Abstract][Full Text] [Related]
9. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction.
Grove EL; Ørntoft TF; Lassen JF; Jensen HK; Kristensen SD
J Intern Med; 2004 Jun; 255(6):637-44. PubMed ID: 15147527
[TBL] [Abstract][Full Text] [Related]
10. Reduced inhibition by abciximab in platelets with the PlA2 polymorphism.
Wheeler GL; Braden GA; Bray PF; Marciniak SJ; Mascelli MA; Sane DC
Am Heart J; 2002 Jan; 143(1):76-82. PubMed ID: 11773915
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty.
Francis SE; Camp NJ; Burton AJ; Dewberry RM; Gunn J; Stephens-Lloyd A; Cumberland DC; Gershlick A; Crossman DC
Heart; 2001 Sep; 86(3):336-40. PubMed ID: 11514491
[TBL] [Abstract][Full Text] [Related]
12. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty.
Hamon M; Bauters C; Amant C; McFadden EP; Helbecque N; Lablanche JM; Bertrand ME; Amouyel P
Circulation; 1995 Aug; 92(3):296-9. PubMed ID: 7634441
[TBL] [Abstract][Full Text] [Related]
13. Ace D/I polymorphism and incidence of post-PTCA restenosis: a prospective, angiography-based evaluation.
Zee RY; Fernandez-Ortiz A; Macaya C; Pintor E; Lindpaintner K; Fernandez-Cruz A
Hypertension; 2001 Mar; 37(3):851-5. PubMed ID: 11244007
[TBL] [Abstract][Full Text] [Related]
14. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty.
Völzke H; Hertwig S; Rettig R; Motz W
Clin Sci (Lond); 2000 Jul; 99(1):19-25. PubMed ID: 10887054
[TBL] [Abstract][Full Text] [Related]
15. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
Hermans WR; Foley DP; Rensing BJ; Serruys PW
Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement.
Böttiger C; Kastrati A; Koch W; Mehilli J; von Beckerath N; Dirschinger J; Gawaz M; Schömig A
Am J Cardiol; 1999 Nov; 84(9):987-91. PubMed ID: 10569651
[TBL] [Abstract][Full Text] [Related]
17. ACE gene polymorphism and coronary restenosis.
Bauters C; Amouyel P; Bertrand ME
Semin Interv Cardiol; 1999 Sep; 4(3):145-9. PubMed ID: 10545620
[TBL] [Abstract][Full Text] [Related]
18. A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study.
Laule M; Cascorbi I; Stangl V; Bielecke C; Wernecke KD; Mrozikiewicz PM; Felix SB; Roots I; Baumann G; Stangl K
Lancet; 1999 Feb; 353(9154):708-12. PubMed ID: 10073513
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty.
van Bockxmeer FM; Mamotte CD; Gibbons FA; Burke V; Taylor RR
Circulation; 1995 Oct; 92(8):2066-71. PubMed ID: 7554183
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of the platelet glycoprotein IIIa Pl(A1/A2) polymorphism in three South African ethnic groups and its effect on platelet function.
Naran NH; Chetty N; Crowther NJ
Thromb Res; 2008; 123(2):316-23. PubMed ID: 18657307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
